DOCSLIB.ORG

Characterisation of Calcium-Sensing Receptor Extracellular Ph

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Characterisation of Calcium-Sensing Receptor Extracellular Ph Characterisation of Calcium-Sensing Receptor Extracellular pH Sensitivity and Intracellular Signal Integration A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy (PhD) in the Faculty of Life Sciences. 2013 Katherine Louisa Campion CONTENTS PAGE LIST OF FIGURES AND TABLES 9 ABBREVIATIONS 13 ABSTRACT 16 DECLARATION 17 COPYRIGHT STATEMENT 18 ACKNOWLEDGEMENTS 19 CHAPTER 1 INTRODUCTION 1.1 Extracellular calcium homeostasis 21 1.1.1 Discovery of the parathyroid gland and its role in calcium homeostasis 21 1.1.2 Discovery of the calcium-sensing receptor its role in calcium homeostasis 22 1.2 Calcium-sensing receptor structure 24 1.2.1 Extracellular domain 24 1.2.2 Venus flytrap and calcium binding domains 24 1.2.3 Glycosylation and the ECD 25 1.2.4 Dimerisation 26 1.2.5 Transmembrane domain 27 1.2.6 TMD extracellular loops 27 1.2.7 TMD Intracellular loops 28 1.2.8 Intracellular domain 29 1.3 Calcium-sensing receptor tissue expression 30 2 1.3.1 Parathyroid gland 31 1.3.2 Kidney 32 1.3.3 Bone 35 1.3.4 Gastrointestinal system 35 1.3.5 Central and peripheral nervous system 36 1.3.6 Blood vessels 37 1.3.7 Developing lung 38 1.3.8 Other tissues 38 1.4 Calcium-sensing receptor pharmacology 38 1.4.1 Orthosteric ligands 38 1.4.2 CaR allosteric modulators – aromatic amino acids 39 1.4.3 Allosteric CaR activators – Calcimimetics 40 1.4.4 Allosteric CaR inhibitors – Calcilytics 41 1.4.5 Effect of extracellular pH on CaR 41 1.5 Diseases of the calcium-sensing receptor and parathyroid gland 46 1.5.1 Loss-of-function CaR mutations 46 1.5.2 Gain-of-function CaR mutations 48 1.5.3 Primary hyperparathyroidism 48 1.5.4 Secondary hyperparathyroidism 49 1.6 Calcium-sensing receptor signalling 49 1.6.1 Phospholipase activation 50 1.6.1.1 Phospholipase C 50 1.6.1.2 Phospholipases A 2 and D 50 1.6.2 Protein kinase regulation 51 3 1.6.2.1 Protein Kinase C 52 1.6.2.2 Protein Kinase A 53 1.6.3 Mitogen-activated protein kinases 54 1.6.3.1 Extracellular-regulated protein kinase 54 1.6.3.2 p38 MAP kinase 55 1.6.3.3 C-Jun N-terminal kinase 55 1.6.4 Calcium-sensing receptor interacting proteins 55 1.6.4.1 Beta arrestin 55 1.6.4.2 Calmodulin 56 1.6.4.3 Potassium channels 57 1.6.4.4 14-3-3 proteins 57 1.6.4.5 Other interactions 58 1.7 Summary 58 1.8 Aims and objectives 59 CHAPTER 2 MATERIALS AND METHODS 60 2.1 Cell culture 61 2.2 Bovine parathyroid cell isolation and culture 61 2.3 Transient cell transfection 61 2.4 Preparation of cell lysates 62 2.5 Immunoblotting 62 2.6 Intracellular calcium imaging 63 2.7 Site-Directed Mutagenesis 63 2.7.1 Mutation primers 64 2.7.2 Sequencing primers 66 4 2.8 Microarray 67 2.9 ERK Assay 68 2.10 Protein references 68 2.11 Statistical analysis 68 CHAPTER 3: MODULATION OF CALCIUM-SENSING RECEPTOR ACTIVITY BY EXTRACELLULAR PH 69 3.1 Introduction 70 3.2 Materials and Methods 70 3.3 Effect of albumin addition on extracellular pH sensitivity in CaR-HEK cells and bovine parathyroid cells 70 3.4 Determination of the contribution of extracellular histidine residues to calcium-sensing receptor pH o-sensitivity 74 3.4.1 Confirmation of each CaR histidine mutant’s base sequence protein expression in HEK-293 cells. 74 3.4.2 Characterisation of the extracellular calcium sensitivity of the CaR histidine mutants expressed abundantly in HEK-293 cells. 75 3.4.3 Characterisation of the extracellular calcium sensitivity of the CaR histidine mutants CaR H41V and CaR H595V 92 3.4.4 Determination of the extracellular pH sensitivity of the CaR histidine mutants that respond to modest extracellular calcium concentrations. 95 3.4.5 Determination of the extracellular pH sensitivity of the CaR histidine mutants CaR H41V and CaR H595V . 110 3.4.6 Characterisation of the extracellular calcium and pH sensitivity of the CaR double histidine mutant, CaRH429V/H495V. 113 3.4.7 Characterisation of the extracellular calcium and pH C482S sensitivity of the free cysteine mutant, CaR . 117 5 3.4.8 Summary 120 3.5 Discussion 121 3.5.1 The effect of altered extracellular pH on the CaR in a heterologous expression system 121 3.5.2 Potential effect of altered calcium binding to albumin following changes in pH o 123 3.5.3 Potential contribution of extracellular histidine residues to CaR pH o sensitivity 124 3.5.4 Extracellular pH sensitivity exhibited by the mGluRs 126 3.5.5 pH sensitivity of non-elemental agonists. 127 3.5.6 pH o sensitivity of CaR mutants 128 3.5.7 Physiological relevance of extracellular pH sensing 128 3.5.8 Summary 131 CHAPTER 4: CALCIUM-SENSING RECEPTOR INTRACELLULAR SIGNALLING INTEGRATION 132 4.1 Introduction 133 4.2 Materials and Methods 133 4.3 Effect of increasing intracellular cAMP on CaR signalling in a heterologous expression system 133 4.3.1 Effect of forskolin addition during CaR-induced 2+ Ca i mobilisation 133 2+ 4.3.2 Effect of forskolin on CaR-induced Ca i mobilisation 2+ at sub-threshold Ca o concentrations 134 2+ 4.3.3 Effect of 1,9-dideoxyforksolin on CaR-induced Ca i 2+ mobilisation at subthreshold Ca o concentrations 136 2+ 4.3.4 Effect of forskolin on CaR-induced Ca i mobilisation 2+ at low Ca o concentration 138 6 2+ 4.3.5 Effect of forskolin on CaR-induced Ca i mobilisation as a function of concentration 138 2+ 4.3.6 Effect of forskolin on CaR-induced Ca i mobilisation as a function of extracellular calcium concentration 139 2+ 4.3.7 Effect of IBMX on CaR-induced Ca i mobilisation at 2+ subthreshold Ca o concentrations 141 4.3.8 Effect of forskolin cotreatment on CaR-induced ERK phosphorylation 142 4.3.9 Effect of chronic phorbol ester pretreatment on 2+ 2+ Ca o–induced Ca i mobilisation 144 4.3.10 Effect of pertussis toxin pretreatment on 2+ 2+ Ca o–induced Ca i mobilisation 146 2+ 4.3.11 Effect of isoproterenol on CaR-induced Ca i 2+ mobilisation at subthreshold Ca o concentrations 149 4.4 Investigation of the role of protein kinase A in CaR signalling 153 4.4.1 Detection of protein kinase A activity using a motif-specific anti-PKA phospho-substrate antibody 153 4.4.2 Effect of protein kinase A inhibition 2+ and forksolin cotreatment on CaR-induced Ca i mobilisation 2+ at moderate Ca o concentration 155 4.4.3 Effect of protein kinase A inhibition 2+ and forksolin cotreatment on CaR-induced Ca i mobilisation 2+ at threshold Ca o concentration 158 4.4.4 Effect of PKA- and EPAC-selective cAMP analogues 2+ 2+ on Ca i mobilisation at moderate Ca o concentration 159 4.4.5 Characterisation of the CaR Ser-899 and Ser-900 mutants 162 2+ 2+ 4.4.6 Effect of forskolin on Ca o–induced Ca i mobilisation in CaR mutants lacking the PKA sites Ser-899 and Ser-900. 167 7 4.5 Discussion 169 4.5.1 The interaction between use of HEK-293 cells as a suitable model of CaR signalling 169 4.5.2 The involvement of cAMP and PKC signalling in parathyroid physiology 170 4.5.3 Effect of cAMP and CaR on the activation threshold 2+ for CaR-mediated Ca i mobilisation 171 4.5.4 Identification of possible cyclic AMP targets in lowering 2+ the agonist threshold for CaR-induced Ca i mobilisation 172 4.5.5 Effect of pertussis toxin on CaR- 2+ mediated Ca i mobilisation 172 4.5.6 Effect of endogenous stimulation of cAMP levels and the potential physiological significance of this effect. 174 2+ 4.5.7 Effect of PKA inhibition on Ca o induced 2+ Ca i mobilisation 177 4.5.8 Functional consequence of mutating the PKA consensus sites in CaR. 178 4.5.9 Possible mechanism of cAMP influence in CaR signalling 180 4.5.10 Relevance of CaR S899A functional data for the concept of agonist-driven insertional signalling 181 4.5.11 Summary 184 CHAPTER 5: GENERAL DISCUSSION. 185 5.1 General discussion 186 5.2 Conclusions 188 REFERENCES 189 WORD COUNT 50,670 8 LIST OF FIGURES AND TABLES Figure 1.1. Schematic overview of extracellular free-ionised calcium homeostasis. 31 Figure 1.2. Schematic of mineral reabsorption in the cortical thick ascending limb. 34 2+ Figure 1.3. Effect of pH o increase on CaR-induced Ca i mobilisation in CaR-HEK cells. 43 2+ Figure 1.4. Effect of pH o increase on CaR-induced Ca i mobilisation in bovine parathyroid chief cells 44 Table 1. CaR extracellular histidine conservation. 45 Figure 1.5. PyMOL model of the extracellular histidines, free- cysteine and putative Ca 2+ binding regions 46 Figure 1.6. Schematic of CaR signalling 50 Table 2. Summary of thermal cycler protocol. 64 Figure 3.1. Effect of pH o on bovine parathyroid cells in the presence of 5% (w/v) albumin 72 Figure 3.2. Effect of pH o on CaR-HEK in the presence of 5% (w/v) albumin 73 Table 3.1. EC 50 values and relative maximal responses for the CaR histidine mutants versus wild-type.
Load more

Recommended publications
  • WO 2013/096741 A2 27 June 2013 (27.06.2013) P CT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/096741 A2 27 June 2013 (27.06.2013) P CT (51) International Patent Classification: (74) Agents: GEORGE, Nikolaos C. et al; Jones Day, 222 A61K 35/12 (2006.01) East 41st Street, New York, NY 10017-6702 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/US20 12/07 1192 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (22) Date: International Filing BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 2 1 December 2012 (21 .12.2012) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (26) Publication Language: English ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (30) Priority Data: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, 61/579,942 23 December 201 1 (23. 12.201 1) US RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, 61/592,350 30 January 2012 (30.01.2012) US TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, 61/696,527 4 September 2012 (04.09.2012) us ZM, ZW. (71) Applicant: ANTHROGENESIS CORPORATION (84) Designated States (unless otherwise indicated, for every [US/US]; 33 Technology Drive, Warren, NJ 07059 (US).
    [Show full text]
  • The Fine Structure of the Parathyroid Gland*
    The Fine Structure of the Parathyroid Gland* BY JERRY STEVEN TRIER, M.D. (From the Department of Anatomy, University of Washington School of Medicine, Seattle) PLATES 3 TO 10 (Received for publication, July 29, 1957) ABSTRACT The fine structure of the parathyroid of the macaque is described, and is cor- related with classical parathyroid cytology as seen in the light microscope. The two parenchymal cell types, the chief cells and the oxyphil cells, have been recognized in electron mierographs. The chief cells contain within their cyto- plasm mitochondria, endoplasmic reticulum, and Golgi bodies similar to those found in other endocrine tissues as well as frequent PAS-positive granules. The juxtanuclear body of the light microscopists is identified with stacks of parallel lamellar elements of the endoplasmic rcticulum of the ergastoplasmic or granular type. Oxyphll cells are characterized by juxtanuclear bodies and by numerous mito- chondria found throughout their cytoplasm. Puzzling lamellar whorls are described in the cytoplasm of some oxyphil cells. The endothelium of parathyroid capillaries is extremely thin in some areas and contains numerous fenestrations as well as an extensive system of vesicles. The possible significance of these structures is discussed. The connective tissue elements found in the perivascular spaces of macaque parathyroid are described. INTRODUCTION Other contributions to the present concepts con cerning the human parathyroid can be found in the It is the purpose of the present paper to report some observations on the fine structure of the reports of Bergstrand (7), Morgan (34), Pappen- parathyroid gland employing the electron micro- heimer and Wilens (45), Castleman and Mallory (10), and Gilmour (20).
    [Show full text]
  • WO 2015/168656 A2 5 November 2015 (05.11.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/168656 A2 5 November 2015 (05.11.2015) P O P C T (51) International Patent Classification: (72) Inventors: HSIAO, Sonny; 1985 Pleasant Valley Avenue, A61K 48/00 (2006.01) Apartment 7, Oakland, CA 9461 1 (US). LIU, Cheng; 24 N Hill Court, Oakland, CA 94618 (US). LIU, Hong; 5573 (21) International Application Number: Woodview Drive, El Sobrante, CA 94803 (US). PCT/US20 15/02895 1 (74) Agents: GIERING, Jeffery, C. et al; Wilson Sonsini (22) International Filing Date: Goodrich & Rosati, 650 Page Mill Road, Palo Alto, CA 1 May 2015 (01 .05.2015) 94304-1050 (US). (25) Filing Language: English (81) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (30) Priority Data: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 61/988,070 2 May 2014 (02.05.2014) US DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (71) Applicant: ADHEREN INCORPORATED [US/US]; HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 1026 Rispin Drive, Berkeley, CA 94705 (US). KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (72) Inventors; and PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (71) Applicants : TWITE, Amy, A.
    [Show full text]
  • Nomenclatore Per L'anatomia Patologica Italiana Arrigo Bondi
    NAP Nomenclatore per l’Anatomia Patologica Italiana Versione 1.9 Arrigo Bondi Bologna, 2016 NAP v. 1.9, pag 2 Arrigo Bondi * NAP - Nomenclatore per l’Anatomia Patologica Italiana Versione 1.9 * Componente Direttivo Nazionale SIAPEC-IAP Società Italiana di Anatomia Patologica e Citodiagnostica International Academy of Pathology, Italian Division NAP – Depositato presso S.I.A.E. Registrazione n. 2012001925 Distribuito da Palermo, 1 Marzo 2016 NAP v. 1.9, pag 3 Sommario Le novità della versione 1.9 ............................................................................................................... 4 Cosa è cambiato rispetto alla versione 1.8 ........................................................................................... 4 I Nomenclatori della Medicina. ........................................................................................................ 5 ICD, SNOMED ed altri sistemi per la codifica delle diagnosi. ........................................................... 5 Codifica medica ........................................................................................................................... 5 Storia della codifica in medicina .................................................................................................. 5 Lo SNOMED ............................................................................................................................... 6 Un Nomenclatore per l’Anatomia Patologica Italiana ................................................................. 6 Il NAP .................................................................................................................................................
    [Show full text]
  • Wednesday Slide Conference 2008-2009
    PROCEEDINGS DEPARTMENT OF VETERINARY PATHOLOGY WEDNESDAY SLIDE CONFERENCE 2008-2009 ARMED FORCES INSTITUTE OF PATHOLOGY WASHINGTON, D.C. 20306-6000 2009 ML2009 Armed Forces Institute of Pathology Department of Veterinary Pathology WEDNESDAY SLIDE CONFERENCE 2008-2009 100 Cases 100 Histopathology Slides 249 Images PROCEEDINGS PREPARED BY: Todd Bell, DVM Chief Editor: Todd O. Johnson, DVM, Diplomate ACVP Copy Editor: Sean Hahn Layout and Copy Editor: Fran Card WSC Online Management and Design Scott Shaffer ARMED FORCES INSTITUTE OF PATHOLOGY Washington, D.C. 20306-6000 2009 ML2009 i PREFACE The Armed Forces Institute of Pathology, Department of Veterinary Pathology has conducted a weekly slide conference during the resident training year since 12 November 1953. This ever- changing educational endeavor has evolved into the annual Wednesday Slide Conference program in which cases are presented on 25 Wednesdays throughout the academic year and distributed to 135 contributing military and civilian institutions from around the world. Many of these institutions provide structured veterinary pathology resident training programs. During the course of the training year, histopathology slides, digital images, and histories from selected cases are distributed to the participating institutions and to the Department of Veterinary Pathology at the AFIP. Following the conferences, the case diagnoses, comments, and reference listings are posted online to all participants. This study set has been assembled in an effort to make Wednesday Slide Conference materials available to a wider circle of interested pathologists and scientists, and to further the education of veterinary pathologists and residents-in-training. The number of histopathology slides that can be reproduced from smaller lesions requires us to limit the number of participating institutions.
    [Show full text]
  • Differentiation of Human Parathyroid Cells in Culture
    417 Differentiation of human parathyroid cells in culture W Liu, P Ridefelt1, G Åkerström and P Hellman Department of Surgery, University Hospital, Uppsala, Sweden 1Clinical Chemistry, University Hospital, Uppsala, Sweden (Requests for offprints should be addressed to P Hellman, Department of Surgery, University Hospital, SE-751 85 Uppsala, Sweden; Email: [email protected]) Abstract Continuous culture of parathyroid cells has proven diffi- histochemistry for proliferating cell nuclear antigen and cult, regardless from which species the cells are derived. In cell counting. Signs of differentiation were present as the the present study, we have used a defined serum-free low set-points, defined as the external calcium concentration at 2+ calcium containing medium to culture human parathyroid which half-maximal stimulation of [Ca ]i (set-pointc), or cells obtained from patients with parathyroid adenomas half-maximal inhibition of PTH release (set-pointp) occur, due to primary hyperparathyroidism. No fibroblast over- were higher in not proliferating compared with prolifer- growth occurred, and the human parathyroid chief cells ating cells in P0. Inhibition of cell proliferation was proliferated until confluent. After the first passage the cells accompanied by signs of left-shifted set-points, indicating ceased to proliferate, but still retained their functional a link between proliferation and differentiation. capacity up to 60 days, demonstrated by Ca2+-sensitive The results demonstrate that human parathyroid chief changes in the release of parathyroid hormone (PTH) and cells cultured in a defined serum-free medium can be kept 2+ ff as adequate cytoplasmic calcium ([Ca ]i) responses to viable for a considerable time, and that signs of di er- changes in ambient calcium as measured by micro- entiation occur after proliferation has ceased.
    [Show full text]
  • Introduction to the Endocrine System: Mechanisms of Disease
    Introduction to the Endocrine System: Mechanisms of Disease Mark J. Hoenerhoff, DVM, PhD, DACVP Associate Professor, In Vivo Animal Core Unit for Laboratory Animal Medicine University of Michigan Medical School 1.1 Lairmore and Rosol, Vet Pathol. 2008 May;45(3):285-286. 1.2 HORMONES CONTROL EVERYTHING!! 1.3 quora.com “CAPEN’S TEN LAWS” OF ENDOCRINE DISEASE 1. Primary Hyperfunction 2. Secondary Hyperfunction 3. Primary Hypofunction 4. Secondary Hypofunction 5. Endocrine Hyperactivity 2o to Other Organ Disease 6. Hypersecretion of Hormones by Non-endocrine Tumors 7. Endocrine Dysfunction due to Failure of Target Cell Response 8. Failure of Fetal Endocrine Function 9. Endocrine Dysfunction 2o to Abnormal Hormone Degradation 10. Syndromes of Iatrogenic Hormone Excess 1.4 Capen CC. Endocrine Glands. In: Maxie G, ed. Jubb, Kennedy & Palmer’s Pathology of Domestic Animals. 5th ed. Elsevier; 2007:325-326. Papadopoulos and Cleare, Nat Rev Endocrinol. 2011 Sept 27;8(1):22-32 1.5 Bassett and Williams, Bone. 2008 Sep;43(3):418-426. 1. PRIMARY HYPERFUNCTION OF ENDOCRINE ORGANS • Often result of functional neoplastic disease of endocrine gland • Autonomous secretion of hormones – DIRECT effect on target organ • Outpaces body’s ability to utilize and degrade hormone • Functional disturbance of hormone excess • Parathyroid chief cell tumors Hyperparathyroidism • Thyroid follicular tumors Hyperthyroidism 1.6 1. PRIMARY HYPERFUNCTION • Parathyroid tumors Hyperparathyroidism Parathyroid PTH Solar Arias et al, Open Vet J. 2016;6(3):165-171. 1.7 Bassett and Williams, Bone. 2008 Sep;43(3):418-426. 1. PRIMARY HYPERFUNCTION • Parathyroid tumors Hyperparathyroidism Parathyroid PTH https://ntp.niehs.nih.gov/nnl/index.htmSolar Arias et al, Open Vet J, 2016 1.7 Bassett and Williams, Bone.
    [Show full text]
  • Thyroid Gland
    10/13/2020 STP Virtual Modular Course 1 Thyroid/Parathyroid: Normal, Background, Induced; Rodent/Nonrodent Terminology; Rodent-Specific Effects I and II Thomas J. Rosol, DVM, PhD, MBA, DACVP, Ohio University Heritage College of Medicine See INHAND: Endocrine (rodents, dog) 2 ©Rosol 2020 1 10/13/2020 Thyroid Gland • Evolution: Conservation of T4 and T3 (mammals, birds, and teleosts) • Structure: Similar • Physiology and metamorphosis: Similarities and dissimilarities • Cancer: Dissimilarities 3 4 ©Rosol 2020 2 10/13/2020 Thyroid Stimulating Hormone (TSH) • Glycoprotein: Alpha & Beta (novel) subunits • Short (~15 minute) half-life • Circulates free (unbound) in blood • Highly species-specific – Human, primate, rat, & dog assays – Little cross reactivity – Male rats greater than females 5 Negative Feedback of the Pituitary by Free T4 • Feedback is dependent on the free hormone – Hypothalamus – Pituitary •Pituitary – 5’ Deiodinase (D2) (intracellular on ER) – Converts T4 to T3 – Serum free T4 correlates with TSH secretion 6 ©Rosol 2020 3 10/13/2020 Relationship of TSH to Free T4 TSH (ng/ml) Free T4 (pM) 7 T4 dose and serum TSH in hypothyroid dog Ferguson DC, 2009, Vet Pharm & Ther 8 ©Rosol 2020 4 10/13/2020 Mouse: TSH Cell Hypertrophy & Hyperplasia (Inhibition of thyroxine synthesis) 9 NIS IHC: 2-month-old Mouse 10 ©Rosol 2020 5 10/13/2020 NIS IHC: 9-month-old Mouse 11 12 ©Rosol 2020 6 10/13/2020 Thyroid Hormone Deiodination • Circulating T3 is not useful to measure thyroid function –Source: liver & kidney plasma membrane deiodinase 1 (D1) • T3 is largely regulated at the cellular level in a tissue- dependent manner (by 5’ deiodinase, D2) 13 Free Serum T4 Between Species TT4 FT4 FT4 Half-life Species (g/dL) (%) (ng/dl) (hours) Rat 4.1 0.05 2.0 13 Dog 2.8 0.10 2.8 15 Cat 1.7 0.10 1.7 11 Human 6.8 0.03 2.0 120 TT4: Total T4, FT4: Free T4 14 ©Rosol 2020 7 10/13/2020 15 Thyroxine Pharmacokinetics Dog and Human (0.22 L/hr) (0.05 L/hr) Kaptein, Am.
    [Show full text]
  • W O 2017/180669 a L 1 9 October 2017 (19.10.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2017/180669 A l 1 9 October 2017 (19.10.2017) P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, C12N 15/90 (2006.01) C12N 15/09 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, C12N 15/87 (2006.01) C07H 21/04 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, (21) International Application Number: KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, PCT/US20 17/027073 MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, (22) International Filing Date: NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, 11 April 2017 ( 11.04.2017) RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (25) Filing Language: English ZA, ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 62/320,863 11 April 2016 ( 11.04.2016) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: APPLIED STEMCELL, INC.
    [Show full text]
  • Parsabiv H-3995
    15 September 2016 EMA/664198/2016 Committee for Medicinal Products for Human Use (CHMP) Assessment report Parsabiv International non-proprietary name: etelcalcetide Procedure No. EMEA/H/C/003995/0000 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged. Table of contents 1. Background information on the procedure .............................................. 6 1.1. Submission of the dossier ..................................................................................... 6 1.2. Steps taken for the assessment of the product ........................................................ 7 2. Scientific discussion ................................................................................ 8 2.1. Introduction ........................................................................................................ 8 2.1.1. Problem statement ............................................................................................ 8 2.1.2. About the product ............................................................................................. 9 2.2. Quality aspects ...................................................................................................
    [Show full text]
  • The Role of Protein Kinase C in the Extracellular Ca2+-Regulated Secretion of Parathyroid Hormone
    Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1384 The Role of Protein Kinase C in the Extracellular Ca2+-regulated Secretion of Parathyroid Hormone BY AMOS M. SAKWE ACTA UNIVERSITATIS UPSALIENSIS UPPSALA 2004 !" !# $ % & ' % % (& & ) % * +, -& . / '&, 0 1. 2 *, !#, -& 3 % ( 4 & / !56' 0 % ( & 7 , 2 , 8#, #6 p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n memory of
    [Show full text]
  • Water-Clear Cell Adenoma of the Mediastinal Parathyroid Gland
    Case Report doi: 10.5146/tjpath.2017.01407 Water-Clear Cell Adenoma of the Mediastinal Parathyroid Gland Deniz ARIK1, Emine DÜNDAR1, Evrim YILMAZ1, Cumhur SİVRİKOZ2 Department of 1Pathology and 2Thorax Surgery, Eskisehir Osmangazi University, Medicine Faculty, ESKİŞEHİR, TURKEY ABSTRACT Water-clear cell adenoma of the parathyroid gland is a rare neoplasm that consists of cells with abundant clear-pink cytoplasm. There have only been 19 cases reported in the English literature. Here we report a case of water-clear cell adenoma of the mediastinal parathyroid gland. A 70-year-old male patient presented to the hospital with back pain and a mediastinal mass 6 cm in size was detected. After excision and microscopic evaluation, uniform, large clear cells with fine cytoplasmic vacuolization, without nuclear atypia, and arranged in solid and acinar patterns were revealed. The cells formed nests that were separated by fine fibrovascular septae and stained positively with anti-parathyroid hormone. To the best of our knowledge, this has not been previously reported in this location. In the differential diagnosis of clear cell lesions of the mediastinum, water-clear cell parathyroid adenoma should be considered. Key Words: Water-clear cell, Adenoma, Ectopic tissue, Mediastinum, Parathyroid gland INTRODUCTION did not have high glycolytic activity. The serum calcium and parathyroid hormone levels were not evaluated. Surgical Water-clear cell parathyroid adenoma (WCCA) is very excision was planned by the initial diagnosis of a bronchial rare. Only nineteen cases have been reported in the English cyst, pathological lymph node or low-grade malignancy. literature (1-17). Water-clear cells (WCCs) are large In open surgery, by intraoperative consultation (frozen polygonal cells with a small nucleus and large optically section) of the biopsy, a lesion with clear cells was seen, but clear cytoplasm.
    [Show full text]